Daniela Vicentini was shocked to be diagnosed with a brain tumor in her early 30s. She shares her symptoms, including ...

The recent report of an astrocytoma following the pyramidal tract (Dec. 7 issue) 1 was quite interesting. We report on the use of fludeoxyglucose F18 positron-emission tomography (PET) in the ...

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an ...

Signatures based on circulating small noncoding RNAs and gene expression profiles can aid rapid and accurate diagnostic evaluation of high-grade astrocytoma, according to two recent studies. Marta ...

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy Sixty-one of 67 children ...

The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery. The Food and Drug Administration (FDA) has approved ...